THE TREVICTA® PLAN
Starting on:
May 23, 2025
Ending on:
May 23, 2025
Moderator(s):
Dr. Silvia Kemunto
Consultant Psychiatrist
Venue:
Radisson Blu Hotel, Nairobi, Upper Hill.
Max Credits:
5 Points

Provider:
Kenya Psychiatrists Association
Claim Points

THE TREVICTA® PLAN

Starting on:
May 23, 2025
Ending on:
May 23, 2025
Venue:
Radisson Blu Hotel, Nairobi, Upper Hill.

Description

"THE TREVICTA® PLAN" is a Continuing Medical Education (CME) event focused on enhancing clinical knowledge and practical approaches in the management of schizophrenia. This session will explore the role of Long-Acting Injectables (LATs), particularly in early treatment, and their impact on patient outcomes. Through expert-led discussions and evidence-based insights, the event aims to equip mental health professionals with effective strategies to optimize long-term treatment planning and support the goal of sustained functional recovery in individuals living with schizophrenia.

Objectives

By the end of this session, participants will be able to: Understand the rationale for early use of Long-Acting Injectables (LATs) in the treatment of schizophrenia and its influence on relapse prevention and adherence. Evaluate clinical evidence supporting LATs, including Trevicta®, in improving long-term patient outcomes and quality of life. Identify and align treatment goals with the evolving therapeutic needs of patients diagnosed with schizophrenia. Apply shared decision-making principles to support individualized, recovery-oriented care plans involving LATs.

Presenters

  1. Dr. Lawrence Nderi
    Consultant Psychiatrist
    MNTRH

  2. Dr. Mercy Karanja
    Consultant Psychiatrist
    MOH

  3. Dr. Pius Kigamwa
    Consultant Psychiatrist
    Nairobi Hosp

Search For CPD Activity